Literature DB >> 811244

The procoagulant factor of leukaemic promyelocytes: demonstration of immunologic cross reactivity with human brain tissue factor.

M Gouault Heilmann, E Chardon, C Sultan, F Josso.   

Abstract

A procoagulant activity was found in the immature cells from patients with acute promyelocytic leukaemia. It was demonstrated that this activity was related to tissue factor. The protein component of tissue factor from brain extract was purified by Nemerson's technique and injected into rabbits to obtain anti-TF antibodies. Similar antibodies were produced against the promyelocyte extract. The anti-brain tissue factor antibodies neutralized the tissue factor activity of promyelocyte extract, and antibodies against immature cells were able to neutralize the tissue factor activity of human brain extract. In immunoprecipitation studies a reaction of partial identity appeared between one component of promyelocyte extract and one component of brain tissue factor. The data demonstrated that the promyelocyte procoagulant is antigenically related to brain tissue factor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811244     DOI: 10.1111/j.1365-2141.1975.tb00529.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Studies on the mechanism of synthesis and release of the procoagulant activity from leukaemic cells.

Authors:  D Mohanty; K Ghosh; K C Das
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 2.  Acute promyelocytic leukaemia in the all trans retinoic acid era.

Authors:  T G DeLoughery; S H Goodnight
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

3.  Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia.

Authors:  G Sunder-Plassmann; W Speiser; C Korninger; M Stain; P Bettelheim; I Pabinger-Fasching; K Lechner
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

4.  Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.

Authors:  I Pabinger; P Bettelheim; R Dudczak; W Hinterberger; P A Kyrle; H Niessner; I Schwarzinger; W Speiser; K Lechner
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

5.  Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis.

Authors:  W Speiser; I Pabinger-Fasching; P A Kyrle; S Kapiotis; A Kottas-Heldenberg; P Bettelheim; K Lechner
Journal:  Blut       Date:  1990-11

6.  Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile.

Authors:  R Sawaya; R F Highsmith
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

7.  Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells.

Authors:  F R Rickles; P D Rick
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

Review 8.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

9.  Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.

Authors:  F Rodeghiero; G Castaman; G Soffiati; R Quaglio; S Castronovo; S Cortesi; E Dini
Journal:  Blut       Date:  1989-08

10.  A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor.

Authors:  S Hartzell; K Ryder; A Lanahan; L F Lau; D Nathan
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.